These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1803767)

  • 1. [A comparative study of the protective properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children].
    Burtseva EI; Obrosova-Serova NP; Govorkova EA; Rudenko LG; Vartanian RV; Beliaev AL; Ivanova VT; Musina MD; Cheshek SG; Zazimko LA
    Vopr Virusol; 1991; 36(5):375-7. PubMed ID: 1803767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children].
    Slepushkin AN; Obrosova-Serova NP; Burtseva EI; Govorkova EA; Rudenko LG; Vartanian RV; Vereshchinskiĭ AI; Musina MD; Lonskaia NI; Zazimko LA
    Vopr Virusol; 1991; 36(5):372-4. PubMed ID: 1803766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88.
    Slepushkin AN; Obrosova-Serova NP; Burtseva EI; Rudenko LG; Govorkova EA; Vartanyan RV; Verestsinsky AI; Lonskaya NI; Harmon MW; Torok T
    Vaccine; 1993; 11(3):323-8. PubMed ID: 8447161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B.
    Sugaya N; Nerome K; Ishida M; Matsumoto M; Mitamura K; Nirasawa M
    JAMA; 1994 Oct; 272(14):1122-6. PubMed ID: 7933325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
    N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].
    Slepushkin AN; Rudenko LG; Kendal AP; Monto AS; Beliaev AL; Burtseva EI; Grigor'eva EP; Obrosova-Serova NP; Ivanova VT; Bragina VE
    Vopr Virusol; 1994; 39(3):129-31. PubMed ID: 8091754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study.
    Helmeke C; Gräfe L; Irmscher HM; Gottschalk C; Karagiannis I; Oppermann H
    PLoS One; 2015; 10(4):e0122910. PubMed ID: 25885063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of the immune response in children multiply inoculated with an inactivated influenza vaccine].
    Rudenko LG; Vasil'eva RI; Smirnova LA; Doroshenko EM
    Vopr Virusol; 1988; 33(4):407-11. PubMed ID: 3195142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of a study of new preparations of inactivated whole-virion influenza vaccines for the protection of children in the USSR].
    Vasil'eva RI; Lonskaia NI; Nefedova LA; Iaroshevskaia IIu; Bichurina MA
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):38-42. PubMed ID: 3591124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral influenza vaccination with live attenuated viruses. 2. Protective efficacy during a type A(H3N2) epidemic.
    Petrilli FL; Crovari P; Cuneo-Crovari P; Badolati G; Canepa R
    Boll Ist Sieroter Milan; 1975 Oct; 54(4):323-30. PubMed ID: 1203088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of annual booster inoculations against various influenza serotypes and the procedure for mass vaccination].
    Slepushkin AN; Schastnyĭ EI; Obrosova-Serova NP; Kobzeva OB; Tomas LP
    Vopr Virusol; 1987; 32(6):656-60. PubMed ID: 3445582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influenza A2 virus strain isolated from children in Moscow and the Moscow region during the 1968-9 epidemic].
    Ritova VV; Schastnyĭ EI; Oganesian OT; Chebotarev VV; Moiseev VP
    Vopr Virusol; 1971; 16(3):291-6. PubMed ID: 5167612
    [No Abstract]   [Full Text] [Related]  

  • 17. [The immunogenic properties and prophylactic efficacy of a live polyvalent influenza vaccine in children 5 to 14 years old].
    Grigor'eva EP; Rekstin AR; Rudenko LG; Ramirez A; Barro M; Lisovskaia KV; Klimov AI; Aleksandrova GI
    Vopr Virusol; 1994; 39(1):26-9. PubMed ID: 8160445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines.
    Ohmit SE; Victor JC; Teich ER; Truscon RK; Rotthoff JR; Newton DW; Campbell SA; Boulton ML; Monto AS
    J Infect Dis; 2008 Aug; 198(3):312-7. PubMed ID: 18522501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong.
    Cowling BJ; Ng S; Ma ES; Cheng CK; Wai W; Fang VJ; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
    Clin Infect Dis; 2010 Dec; 51(12):1370-9. PubMed ID: 21067351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.